Advanced Cell & Gene Therapy CDMO Solutions

Our Capabilities

Bringing Your Cell Therapy Products to the Market

We commit to delivering the highest-quality contract development and manufacturing services to our partners

Success Powered by Cutting-Edge Science

RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, RoslinCT developed, from early process development through commercialization, the First CRISPR-Edited Cell Therapy Product, exa-cel for the treatment of sickle cell disease and transfusion-dependent beta thalassemia.

Let’s Partner Up

0 +

cGMP Batches Produced

for various indications

0 +

cGMP Suites

allowing simultaneous processing

0 +

Experienced Employees

across two continents

0 +

Cell Types

experience supporting auto and allo processes

Purpose-Built cGMP Manufacturing Facilities

Benefit from our world-class, innovative cell therapy development and cGMP manufacturing facilities

RoslinCT-cell-therapy-facility-operations-command-center

01/ 05

Partner with Us

About RoslinCT

Get to Know the Team and What We Stand for

Innovative Solutions. Trusted Partnerships. Life-changing Treatments.

Following the world-breaking first cloning of a mammal (Dolly the Sheep) at the Roslin Institute within the University of Edinburgh (UK) in 1997, there was worldwide interest to access Roslin’s technology and expertise. RoslinCT was established in 2006 to translate this cutting-edge science and apply it to the development of human medicines.